| scholarly article | Q13442814 |
| P50 | author | Felix A Woodhead | Q51144259 |
| P2093 | author name string | Adam Young | |
| Yasmeen Ahmad | |||
| Vadivelu Saravanan | |||
| Mohamed Nisar | |||
| Subha Arthanari | |||
| Julie Dawson | |||
| Gouri Koduri | |||
| Alec N Price-Forbes | |||
| British Rheumatoid Interstitial Lung (BRILL) Network | |||
| Clive A Kelly | |||
| Navtej Sathi | |||
| P2860 | cites work | High resolution computed tomography of the lung in lifelong non-smoking patients with rheumatoid arthritis | Q33567223 |
| Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study | Q33637906 | ||
| Rheumatoid arthritis-interstitial lung disease-associated mortality. | Q33744934 | ||
| Rheumatoid arthritis (RA)-specific autoantibodies in patients with interstitial lung disease and absence of clinically apparent articular RA. | Q33855193 | ||
| A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis | Q33982255 | ||
| 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative | Q34130671 | ||
| Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests | Q35534651 | ||
| Cigarette smoking and rheumatoid arthritis severity | Q35547371 | ||
| Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease | Q36157808 | ||
| QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries | Q36204125 | ||
| Risk factors for the development of rheumatoid arthritis | Q36502903 | ||
| Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease | Q37122572 | ||
| Lung disease in rheumatoid arthritis. | Q37128352 | ||
| The impact of rheumatological evaluation in the management of patients with interstitial lung disease | Q37777902 | ||
| Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ? | Q37845609 | ||
| Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors | Q40532147 | ||
| A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination | Q42676934 | ||
| Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. | Q43227321 | ||
| Anti-cyclic citrullinated peptide-2 (CCP2) autoantibodies and extra-articular manifestations in Greek patients with rheumatoid arthritis | Q44830835 | ||
| Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort. | Q45286659 | ||
| Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells | Q46643896 | ||
| Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia | Q47446738 | ||
| Death rates and causes of death in patients with rheumatoid arthritis: a population-based study | Q47926341 | ||
| Rheumatoid arthritis-related lung diseases: CT findings | Q47976675 | ||
| The influence of sex on the phenotype of rheumatoid arthritis. | Q50888543 | ||
| Interstitial lung disease in recent onset rheumatoid arthritis. | Q50937957 | ||
| Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. | Q51770667 | ||
| P433 | issue | 9 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| interstitial lung disease | Q1153419 | ||
| P304 | page(s) | 1676-1682 | |
| P577 | publication date | 2014-04-23 | |
| P1433 | published in | Rheumatology | Q7320492 |
| P1476 | title | Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics--a large multicentre UK study. | |
| P478 | volume | 53 |
| Q34217084 | A case of pulmonary fibrosis associated with rheumatoid arthritis, scleroderma sine scleroderma and ANCA associated vasculitis |
| Q36183852 | ACPA-positive primary Sjögren's syndrome: true primary or rheumatoid arthritis-associated Sjögren's syndrome? |
| Q51625080 | Acute exacerbation of rheumatoid interstitial lung disease during the maintenance therapy with certolizumab pegol. |
| Q42699610 | An Overview of the Extraarticular Involvement in Rheumatoid Arthritis and its Management |
| Q35674628 | Anti-Cyclic Citrullinated Peptide Antibodies and Severity of Interstitial Lung Disease in Women with Rheumatoid Arthritis |
| Q38857820 | Anti-citrullinated peptide antibodies and their value for predicting responses to biologic agents: a review |
| Q52983676 | Association of disease activity with acute exacerbation of interstitial lung disease during tocilizumab treatment in patients with rheumatoid arthritis: a retrospective, case-control study. |
| Q47101854 | Associations between Viral Infection History Symptoms, Granulocyte Reactive Oxygen Species Activity, and Active Rheumatoid Arthritis Disease in Untreated Women at Onset: Results from a Longitudinal Cohort Study of Tatarstan Women |
| Q39100810 | Biologics-induced interstitial lung diseases in rheumatic patients: facts and controversies |
| Q36799841 | Bronchiectasis is a Model for Chronic Bacterial Infection Inducing Autoimmunity in Rheumatoid Arthritis. |
| Q33582869 | Cardiovascular Comorbidity in Inflammatory Rheumatological Conditions. |
| Q91750406 | Chronic obstructive pulmonary disease in rheumatoid arthritis: a systematic review and meta-analysis |
| Q40597789 | Circulating Interferon-Inducible Protein IFI16 Correlates With Clinical and Serological Features in Rheumatoid Arthritis |
| Q45903141 | Clinical, Epidemiological, and Histopathological Features of Respiratory Involvement in Rheumatoid Arthritis. |
| Q49679284 | Comment on: Patterns of interstitial lung disease and mortality in rheumatoid arthritis |
| Q49679279 | Comment on: Patterns of interstitial lung disease and mortality in rheumatoid arthritis: reply |
| Q51546406 | Computed tomography of pulmonary changes in rheumatoid arthritis: carcinoembryonic antigen (CEA) as a marker of airway disease. |
| Q56985494 | Conceptual model for the health technology assessment of current and novel interventions in rheumatoid arthritis |
| Q35766847 | Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers. |
| Q64881839 | Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: the InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device). |
| Q91867424 | Effect of Biological Disease-modifying Anti-rheumatic Drugs on Airway and Interstitial Lung Disease in Patients with Rheumatoid Arthritis |
| Q38819214 | Effect of rituximab on the progression of rheumatoid arthritis-related interstitial lung disease: 10 years' experience at a single centre |
| Q36201461 | Evaluation of computer-based computer tomography stratification against outcome models in connective tissue disease-related interstitial lung disease: a patient outcome study |
| Q42376403 | Expression of CCR3, SOX5 and LC3 in patients with elderly onset rheumatoid arthritis and the clinical significance |
| Q50316556 | Hearing impairment in patients with rheumatoid arthritis: association with anti-citrullinated protein antibodies |
| Q90372051 | High-resolution computed tomography of the lung in patients with rheumatoid arthritis: Prevalence of interstitial lung disease involvement and determinants of abnormalities |
| Q89449855 | Impact of radiological honeycombing in rheumatoid arthritis-associated interstitial lung disease |
| Q64105507 | Influence of physical rehabilitation on heart rate dynamics in patients with idiopathic pulmonary fibrosis |
| Q26799587 | Intra-thoracic rheumatoid arthritis: Imaging spectrum of typical findings and treatment related complications |
| Q64066828 | Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts |
| Q92578896 | Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 5. Connective Tissue Disease Associated Interstitial Lung Disease |
| Q90415638 | Lung Disease in Rheumatic Disorders |
| Q55361229 | Lung Involvements in Rheumatic Diseases: Update on the Epidemiology, Pathogenesis, Clinical Features, and Treatment. |
| Q39335156 | Lung Manifestations in the Rheumatic Diseases |
| Q57808775 | MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease |
| Q90106982 | Management issues in rheumatoid arthritis-associated interstitial lung disease |
| Q26781712 | Management of Rheumatoid Arthritis Patients with Interstitial Lung Disease: Safety of Biological Antirheumatic Drugs and Assessment of Pulmonary Fibrosis |
| Q38793513 | Management of connective tissue diseases associated interstitial lung disease: a review of the published literature |
| Q92914293 | Mechanisms of lung disease development in rheumatoid arthritis |
| Q51739890 | Nintedanib reduces pulmonary fibrosis in a model of rheumatoid arthritis-associated interstitial lung disease. |
| Q50920476 | Pemphigus vulgaris-associated interstitial lung disease. |
| Q38944886 | Phenome-Wide Association Study of Rheumatoid Arthritis Subgroups Identifies Association Between Seronegative Disease and Fibromyalgia |
| Q47165397 | Pleuropulmonary manifestation in patients with rheumatoid arthritis in Saudi Arabia |
| Q60921512 | Predicting outcomes in rheumatoid arthritis related interstitial lung disease |
| Q89585479 | Predictive factors of mortality in rheumatoid arthritis-associated interstitial lung disease analysed by modified HRCT classification of idiopathic pulmonary fibrosis according to the 2018 ATS/ERS/JRS/ALAT criteria |
| Q36837811 | Predictors of survival in coexistent hypersensitivity pneumonitis with autoimmune features |
| Q39043798 | Presence of anticitrullinated protein antibodies in a large population-based cohort from the Netherlands. |
| Q50108331 | Prevalence and Effects of Emphysema in Never-Smokers with Rheumatoid Arthritis Interstitial Lung Disease. |
| Q41538311 | Prognostic factors in a cohort of antisynthetase syndrome (ASS): serologic profile is associated with mortality in patients with interstitial lung disease (ILD). |
| Q90263056 | Prognostic role of blood KL-6 in rheumatoid arthritis-associated interstitial lung disease |
| Q97538790 | RA-ILD: does more detailed radiological classification add something to our knowledge of this condition? |
| Q38678939 | Recent advances in connective tissue disease related interstitial lung disease |
| Q47289489 | Regulatory roles of micro-RNAs in T cell autoimmunity |
| Q40338691 | Retrospective study of the clinical characteristics and risk factors of rheumatoid arthritis-associated interstitial lung disease |
| Q90415526 | Rheumatoid Arthritis-associated Interstitial Lung Disease in Greece: A Multicentre Epidemiological and Clinical Study |
| Q52940652 | Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis. |
| Q92309196 | Risk Factors and Changes of Peripheral NK and T Cells in Pulmonary Interstitial Fibrosis of Patients with Rheumatoid Arthritis |
| Q90396157 | Risk factors for progression and prognosis of rheumatoid arthritis-associated interstitial lung disease: single center study with a large sample of Chinese population |
| Q33737250 | Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF). |
| Q27027779 | Smoking-related interstitial lung disease |
| Q92417706 | Systematic review and meta-analysis of clinical significance of autoantibodies for idiopathic pulmonary fibrosis |
| Q97521704 | Targeting the Immune System for Pulmonary Inflammation and Cardiovascular Complications in COVID-19 Patients |
| Q37604999 | The 23-valent pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis: a double-blinded, randomized, placebo-controlled trial |
| Q90109539 | The Association Between MUC5B Mutations and Clinical Outcome in Patients with Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Retrospective Exploratory Study in China |
| Q38994767 | The Complex Role of the Lung in the Pathogenesis and Clinical Outcomes of Rheumatoid Arthritis |
| Q64095504 | The natural history of progressive fibrosing interstitial lung diseases |
| Q28082021 | The role of biologics in treatment of connective tissue disease-associated interstitial lung disease |
| Q92384589 | Thoracic Manifestations of Rheumatoid Arthritis |
| Q26775753 | Treatment of rheumatoid arthritis-associated interstitial lung disease: a perspective review |
| Q26825098 | Up-to-Date Information on Rheumatoid Arthritis-Associated Interstitial Lung Disease |
| Q36086758 | Variable course of disease of rheumatoid arthritis-associated usual interstitial pneumonia compared to other subtypes. |
| Q92899755 | [89Zr]Zr-rituximab PET/CT activity in patients with therapy refractory interstitial pneumonitis: a feasibility study |
| Q57176235 | [What rheumatologists can learn from pneumologists] |
Search more.